Silvia Bielsa: Influence Statistics

Silvia Bielsa

Silvia Bielsa

Department of Internal Medicine, Pleural Medicine Unit, Arnau de Vilanova University Hospital, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, ...


Download all Influence Scores

Silvia Bielsa: Expert Impact

Concepts for which Silvia Bielsa has direct influence: Pleural fluid , Pleural effusions , Pleural effusion , Malignant effusions , Parapneumonic effusions , Pleural fluid mesothelin , Pleural exudates .

Silvia Bielsa: KOL impact

Concepts related to the work of other authors for which for which Silvia Bielsa has influence: Pleural effusion , Lung cancer , Adenosine deaminase , Sensitivity specificity , Differential diagnosis , Talc pleurodesis , Tuberculous pleurisy .

KOL Resume for Silvia Bielsa

Year
2022

Department of Internal Medicine, Pleural Medicine Unit, Arnau de Vilanova University Hospital, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, Lleida, Spain

2021

Pleural Medicine Unit, Department of Internal Medicine, Hospital Universitari Arnau de Vilanova, IRBLleida, University of Lleida, Lleida, Spain

2020

Pleural Medicine Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, IRBLleida, Lleida, Spain

2019

Departments of, Internal Medicine, Pleural Medicine Unit

Research Group of Cancer Biomarkers, IRBLleida, Lleida, Spain

2018

Unidad de Medicina Pleural, Servicio de Medicina Interna, Hospital Universitario Arnau de Vilanova, IRBLLEIDA, Lleida, España.

Pleural Medicine Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, IRBLLEIDA, Lleida, Spain

2017

Arnau de Vilanova University Hospital Pleural Medicine Unit, Department of Internal Medicine Lleida Spain

2016

1 Biomedical Research Institute of Lleida Lleida, Spain.

Pleural Medicine Unit, Department of Internal Medicine, Arnau de Villanova University Hospital, Lleida, Spain

2015

Pleural Diseases Unit Department of Internal Medicine Arnau de Vilanova University Hospital Biomedical Research Institute of Lleida Lleida Spain

2014

Department of Internal Medicine, Arnau de Vilanova University Hospital, Lleida, Spain

2013

Servicio de Medicina Interna, Hospital Universitario Arnau de Vilanova, Instituto de Investigación Biomédica de Lleida, Lleida, España

Arnau de Vilanova University Hospital, Biomedical Research Institute of Lleida Pleural Diseases Unit Department of Internal Medicine Lleida Spain

2012

Departments of Internal Medicine

Servicio de Medicina Interna, Hospital Universitario Arnau de Vilanova, Lleida, España

2011

Pleural Diseases Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, Institut de Reçerca Biomèdica de Lleida, Lleida, Spain

Departments of Internal Medicine and Institut de Recerca Biomèdica de Lleida, Lleida

Centre for Respiratory Research, University College London, London, United Kingdom

Depts of Internal Medicine

2010

Pleural Diseases Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, Institut de Recerca Biomèdica de Lleida, Lleida, Spain

2009

1Pleural Disease Unit, Dept of Internal Medicine, 3Dept of Laboratory Medicine, Arnau de Vilanova University Hospital, IRBLLEIDA, Lleida, and 3Service of Internal Medicine, Clinica Recoletas, Albacete, Spain.

Departments of Internal Medicine, Pleural Diseases Unit, Arnau de Vilanova University Hospital, Institut de Recerca Biomèdica de Lleida, Lleida, Spain

2008

Centre for Respiratory Research. University College London. Londres. Reino Unido. España

Department of Internal Medicine, Pleural Diseases Unit, University Hospital Arnau de Vilanova, Unitat de Recerca Biomèdica de Lleida, Lleida, Spain

2007

Pleural Diseases Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, Lleida, Spain

Servicio de Medicina Interna. Hospital Universitario Arnau de Vilanova. Lleida. España

2005

Department of Internal Medicine, Arnau de Vilanova University Hospital, Alcalde Rovira Roure 80, 25198 Lleida, Spain

2004

Department of Internal Medicine, University Hospital Arnau de Vilanova, Lleida, Spain

Prominent publications by Silvia Bielsa

KOL-Index: 15372 . RATIONALE: Serum mesothelin is a new biomarker for the diagnosis of mesothelioma. Patients with mesothelioma commonly present with pleural effusions. To define the clinical utility of mesothelin quantification in pleural fluid, we assessed its additional value over pleural fluid cytology and its short-term reproducibility and reliability after pleural inflammatory processes, including ...
Known for Pleural Fluid | Patients Mesothelioma | Clinical Impact | Cytological Examination
KOL-Index: 12135 . BACKGROUND: The objective of this study was to compare the diagnostic accuracy of pleural fluid brain natriuretic peptide (BNP), N-terminal pro-BNP (NT-pro-BNP) and ST2, which are biomarkers of myocyte stress, for diagnosing pleural effusions due to heart failure (HF). BNP and ST2 have not been previously evaluated in pleural fluid. METHODS: The three biomarkers were measured in the ...
Known for Pleural Fluid | Heart Failure | Hf Bnp | Natriuretic Peptide
KOL-Index: 11548 . We aimed to investigate whether pleural fluid concentrations of biomarkers for bacterial infection, namely triggering receptor expressed on myeloid cells (sTREM-1), procalcitonin (PCT), lipopolysaccharide-binding protein (LBP) and C-reactive protein (CRP), might identify infectious effusions and discriminate between complicated (CPPEs) and uncomplicated parapneumonic effusions (UPPEs). ...
Known for Pleural Effusions | Differential Diagnosis | Crp Lbp | Bacterial Infection
KOL-Index: 10887 . BACKGROUND: The role of fluorodeoxyglucose (FDG)-PET imaging for diagnosing malignant pleural effusions is not well defined. The aim of this study was to summarize the evidence for its use in ruling in or out the malignant origin of a pleural effusion or thickening. METHODS: A meta-analysis was conducted of diagnostic accuracy studies published in the Cochrane Library, PubMed, and Embase ...
Known for Malignant Pleural | Differentiating Benign | Pet Imaging | Lung Cancer
KOL-Index: 9358 . BACKGROUND AND AIMS: Prompt identification of parapneumonic effusions has immediate therapeutic benefits. We aimed to assess whether C-reactive protein (CRP) and routine biochemistries in pleural fluid are accurate markers of parapneumonic effusions, and to evaluate their properties as indicators for drainage (complicated parapneumonic effusion). METHODS: A retrospective review of 340 ...
Known for Parapneumonic Effusions | Pleural Fluid | Reactive Protein | Crp Levels
KOL-Index: 9031 . BACKGROUND AND OBJECTIVE: The clinical relevance of pleural effusions in lung cancer has seldom been approached systematically. The aim of this study was to determine the prevalence, causes and natural history of lung cancer-associated pleural effusions, as well as their influence on survival. METHODS: Retrospective review of clinical records and imaging of 556 consecutive patients with a ...
Known for Pleural Effusions | Lung Cancer | Patients Malignant | Diagnostic Thoracentesis
KOL-Index: 8518 . OBJECTIVE: To determine the diagnostic utility of adenosine deaminase (ADA) in a large series of pleural effusions of different etiologies. METHODS: A retrospective study of 2104 consecutive patients presenting with pleural effusion was carried out at a Spanish university hospital. ADA levels in pleural fluid were determined using a non-Giusti automatic kinetic assay, and a receiver ...
Known for Pleural Fluid | Adenosine Deaminase | Diagnostic Performance | Malignant Predictive
KOL-Index: 8439 . We sought to determine whether measuring antinuclear antibodies (ANA) and their specificities [dsDNA, extractable nuclear antigens (ENA)] on pleural fluid may contribute to the differential diagnosis of pleural effusions. ANA were tested by indirect immunofluorescence on Hep-2 cells in the pleural fluid of 266 patients with effusions of different etiologies, including 15 lupus pleuritis. ...
Known for Pleural Fluid | Lupus Pleuritis | Antinuclear Antibodies | Differential Diagnosis
KOL-Index: 8179 . BACKGROUND: The clinical course of patients with malignant pleural effusions (MPEs) varies. The decision to undertake "definitive therapy" (pleurodesis, indwelling pleural catheter [IPC], or both) for MPEs is decided on a case-by-case basis. Identifying factors that predict definitive therapy may help guide early initiation of treatment. The aim of the study was to identify clinical, ...
Known for Pleural Effusion | Definitive Therapy | Patients Mpe | Clinical Pleurodesis
KOL-Index: 7853 . BACKGROUND AND OBJECTIVE: Some clinical variables are associated with bacteremia in patients with community-acquired pneumonia (CAP). The aim of this study was to analyse the accuracy of the soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict positive blood cultures in comparison with established clinical prognostic variables. METHODS: In addition to ...
Known for Triggering Receptor | Myeloid Cells | Acquired Pneumonia | Serum Strem1
KOL-Index: 7760 . Background Pleurofibrinolysis has been reported to be potentially beneficial in the management of complicated parapneumonic effusions (CPPE) and empyemas in the adult population. Methods Prospective, controlled, randomized, and double-blind study, to evaluate intrapleural alteplase 10 mg (initially 20 mg was considered but bleeding events forced dose reduction) versus 100,000 UI urokinase ...
Known for Cppe Empyemas | Pleural Effusion | Activator Treatment | Urokinase Versus
KOL-Index: 7277 . BACKGROUND: To determine the effects of the biochemical and cytological properties of the pleural fluid (PF) on the survival of patients with malignant pleural effusion (MPE). METHODS: A retrospective study of 284 patients with MPE was performed, which measured overall survival, survival of patients with different types of primary tumors, and survival as a function of PF biochemical ...
Known for Pleural Fluid | Patients Mpe | Prognostic Significance | Malignant Effusion
KOL-Index: 7195 . The presence of leukocyte subpopulations in malignant pleural effusions (MPEs) can have a different impact on tumor cell proliferation and vascular leakiness, their analysis can help to understand the metastatic microenvironment. We analyzed the relationship between the leukocyte subpopulation counts per ml of pleural fluid and the tumor cell count, molecular phenotype of lung ...
Known for Malignant Pleural Effusions | Lung Adenocarcinoma | Tumor Cells | Cd4 Cd8
KOL-Index: 7098 . An automated nucleic acid amplification assay that simultaneously identifies Mycobacterium tuberculosis and rifampicin resistance, the Xpert® MTB/RIF test, has undergone extensive evaluation in sputum samples. Our aim was to define its diagnostic accuracy when performed on pleural fluid specimens. In 67 patients with pleural effusions, of whom half had tuberculous pleuritis, Xpert yielded ...
Known for Xpert Mtb | Pleural Fluid | Mycobacterium Tuberculosis | Rifampicin Resistance
KOL-Index: 6761 . Although empyema affects more than 65,000 people each year in the United States and in the United Kingdom, there are limited data on the pathogenesis of pleural infection. We investigated the pathogenesis of empyema using animal and cell culture models of Streptococcus pneumoniae infection. The pathological processes during the development of empyema associated with murine pneumonia due to ...
Known for Streptococcus Pneumoniae | Development Empyema | Pleural Space | D39 Strain

Key People For Pleural Fluid

Top KOLs in the world
#1
Richard W Light
pleural effusion pulmonary embolism pleurodesis rabbits
#2
Steven A Sahn
pleural fluid idiopathic pulmonary fibrosis mechanical ventilation
#3
Wilmot C Jr Ball
tumor embolization bronchogenic carcinoma pleural fluid
#4
Richard W Light
pleural fluid nebulized isoproterenol diagnostic significance
#5
M Isabelle MacGregor
chronic sarcoidosis pleural fluid corticosteroid treatment
#6
Peter C Luchsinger
pleural fluid nebulized isoproterenol diagnostic significance

Department of Internal Medicine, Pleural Medicine Unit, Arnau de Vilanova University Hospital, Biomedical Research Institute of Lleida (IRBLleida), University of Lleida, Lleida, Spain | Pleural Medicine Unit, Department of Internal Medicine, Hospital